Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

Back

Raveendran  Pottathil, PhD

Raveendran Pottathil, PhD

President of Accudx Inc,
Florida International University
USA

Biography

Ravi Pottathil is President of Accudx Inc., a strategic technology and consulting company. Dr. Pottathil is an entrepreneur with a 40-year history spanning academia, industry, invention, and company creation. In 1996, Dr. Pottathil created Accudx as a diagnostic assay manufacturer. This company has progressed into consulting, technology and product development, and intellectual property services in biotech, medtech, and ecotech. His experience in academia and industry has covered various aspects of biochemistry, molecular biology, mammalian genetics, medical virology, tumor biology, and diagnostics, in both academic and industrial settings. As Chief Process Scientist at PetroAlgae, he was responsible for the development and scale up processes for growth, harvesting and processing of micro-algae. As a founding member and Director at Specialty Laboratories International, he successfully set up a large number of esoteric Clinical Reference Laboratories in Mexico, Singapore, Malaysia, and India. This involved extensive project planning, technical training and technology transfer. As a Vice President of Life Sciences at XLTech Group, he was co-founder of a number of publically listed companies including Tyratech [www.tyratech.com], Petro Algae, [www.parabel.com] and Initio Fuels [www.initiofuels.com]. As an academician, he has extensive teaching experience that includes original research and teaching at The Jackson Laboratories, The Duke University, University Of Maryland, The City of Hope Medical Center, The Rutgers University, Ambala College of Engineering, India, A&F University, Yangling, China and Florida International University. He has a number of issued patents. Current active projects of Dr. Pottathil include “target specific nano-ablation” of cancer highly sensitive nanotechnology based Point of Care Devises for the early detection of infectious diseases such as dengue, malaria, HIV and TB. He is also leading research and development activities related to non-toxic natural essential oil based insect control and chelated micronutrient based enhanced biomass and food production. Dr. Pottathil is a graduate of Tata Cancer Institute in Mumbai, India. He completed his post-doctoral fellowships at The Jackson Lab, Bar Harbor, ME and Duke University, NC. He worked as a Senior Manager at Hoffman La-Roche and was instrumental in their diagnostics program. He is currently a visiting professor at Florida International Univ. Miami.

Research Interest

nano delivery systems, aptamers and nano formulations.